Swethajit Biswas

Company: CDR-Life Inc

Job title: Chief Medical Officer

Seminars:

1.00 Back-Tracking Breakthroughs for BITEs & Cell Engagers to Gain Reverse Translation Insights 1:00 pm

Post-approval studies offer a real-world lens on the long-term safety, efficacy, and practical applications of cell engager drugs, providing crucial insights into diverse patient populations and clinical scenarios. By incorporating back translation strategies developers can transform insights into actionable lessons to overcome limited animal models to mimic systemic immune response in patients and improve safety…Read more

day: Workshop D